What can we do about indirect comparisons to make it better and more efficient rather than using the usual technique?
What are the indirect comparisons in terms of the efficacy of different drugs?
What experiences have you had when the type of one-to-one approach is better?
In today’s episode, Daniel and I talk about these questions and discuss more the following points:
- Bucher vs MAIC – advantages and disadvantages
- Methodik MAIC
- NICE technical document (http://nicedsu.org.uk/technical-support-documents/population-adjusted-indirect-comparisons-maic-and-stc/) – including R code

Dr. Alexander Schacht
What can we do about indirect comparisons to make it better and more efficient rather than using the usual technique?
What are the indirect comparisons in terms of the efficacy of different drugs?
What experiences have you had when the type of one-to-one approach is better?
In today’s episode, Daniel and I talk about these questions and discuss more the following points:
- Bucher vs MAIC – advantages and disadvantages
- Methodik MAIC
- NICE technical document (http://nicedsu.org.uk/technical-support-documents/population-adjusted-indirect-comparisons-maic-and-stc/) – including R code
Everything you need to know about matching adjusted indirect comparisons

Dr. Alexander Schacht
What can we do about indirect comparisons to make it better and more efficient rather than using the usual technique?
What are the indirect comparisons in terms of the efficacy of different drugs?
What experiences have you had when the type of one-to-one approach is better?
In today’s episode, Daniel and I talk about these questions and discuss more the following points:
- Bucher vs MAIC – advantages and disadvantages
- Methodik MAIC
- NICE technical document (http://nicedsu.org.uk/technical-support-documents/population-adjusted-indirect-comparisons-maic-and-stc/) – including R code
